SynCrest Inc.

Japanese CRDMO specializing in middle-molecule drugs including peptides, nucleic acids, and lipids. Joint venture between Otsuka Chemical (51%) and Yokogawa Electric (49%). Provides contract manufacturing of peptides from raw materials to APIs under GMP using solid-phase and continuous flow synthesis. Naruto Factory handles GMP production for highly active substances (OEB Category 4). Also manufactures non-natural amino acids and amidites with a library of hundreds of compounds. Capable of mg to kg-scale flexible production.

SynCrest Inc. is listed as a cdmo in the peptide supply chain, serving Asia markets from Japan. As a direct manufacturer, this supplier controls its own production process from synthesis through purification and quality control release testing. Verification is supported by 2 independent sources, including documentation review and cross-referencing against public records. This supplier has a strong confidence score, indicating a high level of verification and reliability for B2B sourcing.